Phase I study of gemcitabine and vinorelbine in nonsmall cell lung cancer (NSCLC)-elderly patients

被引：0
|
作者：
Santomaggio, C
Portalone, L
Seebacher, C
Bazzicalupo, F
Soresi, E
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Phase I/II Study of Gemcitabine plus Vinorelbine in Non-Small Cell Lung Cancer
    Emilio Esteban
    Joaquin Fra
    Norberto Corral
    Miguel Valle
    Juan Carrasco
    Marian Sala
    Javier Puerta
    Enrique Estrada
    Isabel Palacio
    Jose Maria Vieitez
    Jose Maria Buesa
    Angel Jimenez Lacave
    Investigational New Drugs, 2002, 20 : 73 - 82
  • [22] Gemcitabine (G), ifosfamide (I), vinorelbine (N) in advanced non-small cell lung cancer (NSCLC):: A phase II study.
    Morère, JF
    Pailler, MC
    Saintigny, P
    Bréchot, JM
    Morin, F
    Mir, D
    Martinez, A
    Breau, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 705S - 705S
  • [23] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [24] Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC).
    Ramnath, N
    Sommers, E
    Robinson, L
    Nwogu, C
    Tan, D
    Sharma, A
    Cantor, A
    Lawrence, D
    Simon, G
    Bepler, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 689S - 689S
  • [25] Vinorelbine and carboplatin in elderly patients with metastatic non-small cell lung cancer (NSCLC): A multicenter phase II study
    Deppermann, Karl-Matthias
    Ukena, Dieter
    von Pawel, Joachim
    Koschel, Gabriele
    Reck, Martin
    Serke, Monika
    Huber, Rudolf-Maria
    Eberhardt, Wilfried
    Niederle, Norbert
    ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [26] Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer - West Japan Thoracic Oncology Group (WJTOG) 0104
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    Uejima, Hisao
    Sugiura, Takahiko
    Takada, Yoshiki
    Negoro, Shun-ichi
    Matsui, Kaoru
    Kashii, Tatsuhiko
    Takada, Minoru
    Nakanishi, Yoichi
    Kato, Terufumi
    Fukuoka, Masahiro
    CANCER, 2006, 107 (03) : 599 - 605
  • [27] Phase I II study of CDDP plus vinorelbine plus gemcitabine in non-small cell lung carcinoma (NSCLC).
    Esteban, E
    Fra, J
    Puertas, J
    Sala, MA
    Carrasco, J
    Palacio, I
    Muñiz, I
    Vieitez
    Lacave, AJ
    Buesa, JM
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S62 - S62
  • [28] GEMCITABINE / PLATINUM VS. VINORELBINE-PLATINUM IN PATIENTS WITH ADVANCED NONSMALL- CELL LUNG CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2008, 14 (01): : 51 - 54
  • [29] Phase II study of gemcitabine-vinorelbine followed by docetaxel in elderly patients with advanced non-small cell lung cancer
    José-Luis, F
    Gaspar, E
    Sergio, V
    Eva, P
    Cristina, L
    Luis, L
    Margarita, A
    Carlos, G
    Mercedes, S
    José-Ramón, M
    LUNG CANCER, 2005, 49 : S249 - S249
  • [30] Pilot Phase II Study of Gemcitabine and Vinorelbine in Patients with Recurrent or Refractory Small Cell Lung Cancer
    Arkadiusz Z. Dudek
    Krzysztof Leśniewski-Kmak
    Robin L. Bliss
    Claudio Brunstein
    Debra L. Condon
    Robert A. Kratzke
    Lung, 2005, 183 : 43 - 52
12345